It’s time to gain some insight directly from Egypt. If you want to learn more about their local perspective on the Focused Update of the Guidelines, register and join the upcoming LCN webinar: https://t.co/34xEPgq44K
Episode one of IAS’ Leading Insights series with Prof. Raul Santos (@rauldsf_santos) and Prof. Gerald Watts discusses the PALISADE study’s findings, noting how plozasiran demonstrated it can meet the treatment gap for patients with #FamilialChylomicronemiaSyndrome whether the rare disease is clinically defined or genetically confirmed.
This #FCSAwarenessDay, take some time to watch this episode and learn more: https://t.co/9tIQtypjzO
🚨⚡️BREAKING AND UNUSUAL
Egyptian President Abdel Fattah el-Sisi attends the opening ceremony of the Grand Egyptian Museum with the participation of 79 official delegations from various countries around the world.
The historic event is described as "Egypt's gift to the world" and is considered the largest archaeological museum in modern history. 🇪🇬
Located on the doorstep of Cairo's famed Giza Pyramids, the world's largest archaelogical museum is officially opening. Packed with over 50,000 artefacts covering seven millennia of ancient Egyptian civilization.
https://t.co/0ogADVKq8j
A terrific EAS Advanced Course on Non-Classical Risk Factor. I would like to sincerely thank the @society_eas for the opportunity to organize this event and for their continuous commitment in education. The meeting have been truly inspiring. Thanks to all friends a and colleagues
Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy – should we propose these patients to intervention? More on the potential outcomes in https://t.co/y3rv984Giy
#EHJQCCO#AFib#HCM#PVI@cpgale3@diogoasantosfer@m_piepoli
We’re thrilled to be in Vienna for the second event in the EAS Advanced Course series on non-classical risk factors! Take a look at the programme and discover the thought-provoking discussions happening today. @ProfKausikRay@KatiOorni
Episode 7 of the BCRI Atherosclerosis Webinar Series is now live!
IAS, in collaboration with @Cleerlyhealth, Mike Gibson, MS, MD (@CMichaelGibson), and @WomenAs1 have released a new installment of the series.
Watch episode 7 featuring Marc Bonaca, MD, MPH (@MarcBonaca), to hear a discussion on asymptomatic CAD screening: https://t.co/g4JPJEcLLW
🚀 The Quantum Leap of Photon-Counting CT ⚡️
For decades, CT technology evolved step by step — faster rotation, thinner slices, dual energy…
Then came Photon-Counting CT (PCCT) — and everything changed.
🧠 Unlike conventional CT detectors that integrate X-ray energy, PCCT counts individual photons and measures their energy directly.
That means:
Ultra-sharp spatial resolution (down to 0.1 mm)
No electronic noise
True multi-energy imaging
Cleaner images at lower dose
❤️ In cardiovascular imaging, this feels like putting on glasses for the first time.
Suddenly, stents, calcifications, and vessel walls appear crisp and separable — details once blurred or lost in blooming artifacts are now perfectly delineated.
We’re no longer limited by hardware noise; we’re limited only by imagination.
Photon-Counting CT isn’t just an upgrade — it’s a quantum leap.
In the movie the same stent in the LAD with conventional latest CT with EiD technology and then with Dual Source Photon Counting CT.
#PhotonCountingCT #PCCT #CardiacImaging #CTRevolution #MedicalImaging #Innovation #Radiology #Cardiology #PrecisionMedicine
The benefit of Ozempic (semaglutide) for protection from major adverse cardiovascular events (MACE) is independent of weight loss magnitude and baseline adiposity, likely related to the GLP-1 anti-inflammatory effect
https://t.co/y44fRowTGi
📅 MARK YOUR CALENDAR 📅
The 21st International Symposium on Atherosclerosis is scheduled for October 20-22, 2027 in Santiago, Chile!
#ISA2027 will bring together clinicians, scientists, policymakers and patient advocates from across the globe under the theme, "Cardiometabolic Health Unlocked: From Genetics to Global Impact."
Thank you to IAS member @ateros_chile for its partnership in co-hosting this event. Look for more information to be released soon!
See you in #Santiago!
New Residual Risk Score!
Now you can calculate almost immediately the 10-year risk of your patient who has prior ASCVD
The risk calculator is free online & outperforms existing risk assessment algorithms:
https://t.co/QiFraFlb6m